Clinical trial Recruiting at 1 site Interventional Ages 10 to 13

PRETA: a digital school program to prevent eating disorders in fifth- and sixth-grade students.

Official title: Effectiveness and Cost-effectiveness of an Online School-based Program for Reducing Risk Factors in Pre-adolescents (PRETA): Protocol for a Cluster Randomized Controlled Trial

Run by Servicio Canario de Salud · NCT06792981 · Data updated 2026-11-12

This trial will test a nine‑session online school program (PRETA) to see if it reduces eating-disorder risk and related factors in fifth- and sixth-grade students.

Quick facts

Study typeInterventional
Ages10 Years to 13 Years
SexAll
Enrollment1068 (estimated)
SponsorServicio Canario de Salud
Academic / other
Locations1 site (Santa Cruz de Tenerife, Santa Cruz de Tenerife)
StatusRecruiting
StartedMarch 10, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedSeptember 19, 2025
Trial IDNCT06792981 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are students enrolled in the fifth or sixth year of primary school at participating schools whose legal guardians and responsible teacher provide informed consent and who can engage with online materials.

Probably not a fit

Children with significant comprehension difficulties that prevent adequate participation in the online sessions or questionnaires are unlikely to benefit from the program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PRETA program is a universal, ICT-delivered prevention intervention culturally adapted from the POtsdam Prevention at Schools (POPS) program for pre-adolescents. It consists of nine online sessions delivered within participating primary schools and targets modifiable risk factors such as body dissatisfaction and unhealthy eating attitudes. The study is a matched-pair cluster randomized trial with schools as clusters, assigning six schools to each arm to compare PRETA with control. Researchers will also conduct an analysis of program efficiency from a social perspective, and participation requires parental consent and adequate student comprehension.

Why it matters

Potential benefit: If successful, PRETA could lower the number of pre-adolescents who go on to develop eating disorders by reducing key modifiable risk factors and reaching many students at relatively low cost.

How similar studies have gone: Previous school-based and ICT-facilitated prevention programs, including components of the POtsdam POPS approach, have shown positive effects in at-risk youth, although universal digital interventions for preadolescents are less extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Enrolled in the fifth or sixth year of primary education.
* Informed consent provided by the student's legal guardians and responsible teacher to participate.

Exclusion Criteria:

* Significant comprehension difficulties that limit adequate participation in the program and questionnaires.

Where it's running

  • Servicio de Evaluación y Planificación del Servicio Canario de Salud
    Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain
    Recruiting

Study contacts

  • Principal investigator: Yolanda Ramallo-Fariña, PhD in Biomedical Sciences — Servicio de Evaluación del Servicio Canario de la Salud
  • Study coordinator: Yolanda Ramallo-Fariña, PhD in Biomedical Sciences
  • Email: yolanda.ramallofarina@sescs.es
  • Phone: +34922478266

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.